Institute of Bio-Stem Cell Rehabilitation

The Institute of Bio-Stem Cell Rehabilitation (IBSR) is a South Korean biotechnology company specializing in the research and development of regenerative medicine therapies. As the core research entity of the Biostar Group, IBSR focuses on autologous adipose-derived mesenchymal stem cell (AD-MSC) technology to treat chronic and degenerative conditions. Its lead program, Joint-Stem, is a non-surgical treatment for knee osteoarthritis that has reached late-stage clinical trials in South Korea and the United States. Beyond orthopedics, the institute is advancing a pipeline of cell therapies for Alzheimer's disease, spinal cord injuries, and autoimmune disorders. IBSR operates specialized cell-culturing facilities and maintains a strong focus on clinical translation through its affiliate, Nature Cell. The company's mission is to provide safe and effective stem cell rehabilitation options that improve patient quality of life.